BRTX vs OKE · rev $401.0K vs P/E 15, rev $21.70B
BioRestorative Therapies Inc (BRTX) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
BRTX currently screens at market cap $10.2M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the BRTX and OKE stock pages for the full models.
Not investment advice.